Compare PLSE & GBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PLSE | GBDC |
|---|---|---|
| Founded | 2014 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.4B |
| IPO Year | 2015 | 2009 |
| Metric | PLSE | GBDC |
|---|---|---|
| Price | $47.02 | $13.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $22.00 | $14.38 |
| AVG Volume (30 Days) | 453.4K | ★ 1.1M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 11.69% |
| EPS Growth | N/A | ★ 4.41 |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | N/A |
| Revenue This Year | $840.00 | N/A |
| Revenue Next Year | $287.54 | N/A |
| P/E Ratio | ★ N/A | $45.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.56 | $11.77 |
| 52 Week High | $48.10 | $14.93 |
| Indicator | PLSE | GBDC |
|---|---|---|
| Relative Strength Index (RSI) | 78.25 | 53.66 |
| Support Level | $24.27 | $12.70 |
| Resistance Level | N/A | $13.45 |
| Average True Range (ATR) | 3.09 | 0.24 |
| MACD | 0.62 | 0.01 |
| Stochastic Oscillator | 98.50 | 61.69 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Golub Capital BDC Inc. is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in U.S. middle-market companies. It also invests in second-lien and subordinated loans, warrants, and minority equity securities in U.S. middle-market companies. The company generally invests in securities rated below investment grade by independent rating agencies, or those that would be rated below investment grade if evaluated. The company operates in the USA, Canada, and other countries, with the majority of its revenue coming from the USA.